Blog Archives

Blog

How to build standardized eCRFs across multiple EDC systems

Discover how to build standardized eCRFs across multiple EDC systems to improve data quality, accelerate…

CertaraDecember 12, 2025

Blog

7 key annotated CRF regulatory submission requirements you should know

Discover 7 key aCRF regulatory submission requirements for delivering high-quality annotated CRFs, including real-world examples…

CertaraDecember 10, 2025

Blog

Virtual Triplets: The Next Step in Personalized and Ethical Drug Development

Learn how virtual triplets, linking PBPK, QSP, and organ-on-a-chip technologies, are transforming model-informed drug development,…

CertaraDecember 9, 2025

Blog

The Stepwise PIP is Here to Stay: From Pilot Flexibility to Permanent EU Regulation

The stepwise Paediatric Investigation Plan (PIP) is a strategic, flexible route for drug developers navigating…

CertaraNovember 26, 2025

Blog

Certara’s Virtual Twin® QSP Models: Transforming Rare Disease Research into Clinical Insights

Certara’s Virtual Twin® QSP Models are transforming rare disease drug development, with real-world insights from…

CertaraNovember 25, 2025

Blog

The Proposed Food and Drug Administration (FDA) Development Safety Update Report (DSUR) Guidance

Learn how FDA DSUR requirements reshape drug safety reporting, align with ICH E2F, and impact…

CertaraNovember 24, 2025

Blog

From Insight to Impact: Certainty EMEA 2025

See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…

CertaraNovember 17, 2025

Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.

CertaraNovember 14, 2025

Blog

Using M&S to Evaluate Oncology Drug Dosing

Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…

CertaraNovember 14, 2025

Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

CertaraNovember 13, 2025

Blog

How to build standardized eCRFs across multiple EDC systems

7 key annotated CRF regulatory submission requirements you should know

Virtual Triplets: The Next Step in Personalized and Ethical Drug Development

The Stepwise PIP is Here to Stay: From Pilot Flexibility to Permanent EU Regulation

Certara’s Virtual Twin® QSP Models: Transforming Rare Disease Research into Clinical Insights

The Proposed Food and Drug Administration (FDA) Development Safety Update Report (DSUR) Guidance

From Insight to Impact: Certainty EMEA 2025

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Using M&S to Evaluate Oncology Drug Dosing

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Newsletter sign up

Quick links

Solutions

Contact